140 related articles for article (PubMed ID: 38256412)
1. Spine Metastasis Is Associated with the Development of Brain Metastasis in Non-Small-Cell Lung Cancer Patients.
Cha HK; Ryu WK; Lee HY; Kim HJ; Ryu JS; Lim JH
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256412
[No Abstract] [Full Text] [Related]
2. The Impact of Time Interval on Prognosis in Patients with Non-Small Cell Lung Cancer Brain Metastases After Metastases Surgery.
Yang Z; Chen H; Jin T; Sun L; Li L; Zhang S; Wu B; Jin K; Zou Y; Sun C; Xia L
World Neurosurg; 2023 Dec; 180():e171-e182. PubMed ID: 37704036
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impacts of extracranial metastasis on non-small cell lung cancer with brain metastasis: A retrospective study based on surveillance, epidemiology, and end results database.
Wang M; Wu Q; Zhang J; Qin G; Yang T; Liu Y; Wang X; Zhang B; Wei Y
Cancer Med; 2021 Jan; 10(2):471-482. PubMed ID: 33320433
[TBL] [Abstract][Full Text] [Related]
4. Zebrafish xenograft model for studying mechanism and treatment of non-small cell lung cancer brain metastasis.
Fan RY; Wu JQ; Liu YY; Liu XY; Qian ST; Li CY; Wei P; Song Z; He MF
J Exp Clin Cancer Res; 2021 Nov; 40(1):371. PubMed ID: 34801071
[TBL] [Abstract][Full Text] [Related]
5. The Thr300Ala variant of ATG16L1 is associated with decreased risk of brain metastasis in patients with non-small cell lung cancer.
Li QX; Zhou X; Huang TT; Tang Y; Liu B; Peng P; Sun L; Wang YH; Yuan XL
Autophagy; 2017 Jun; 13(6):1053-1063. PubMed ID: 28441070
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer.
Baek MY; Ahn HK; Park KR; Park HS; Kang SM; Park I; Kim YS; Hong J; Sym SJ; Park J; Lee JH; Shin DB; Cho EK
Korean J Intern Med; 2018 Jan; 33(1):168-175. PubMed ID: 27093978
[TBL] [Abstract][Full Text] [Related]
7. Down-regulated microRNA-375 expression as a predictive biomarker in non-small cell lung cancer brain metastasis and its prognostic significance.
Chen LJ; Li XY; Zhao YQ; Liu WJ; Wu HJ; Liu J; Mu XQ; Wu HB
Pathol Res Pract; 2017 Aug; 213(8):882-888. PubMed ID: 28688608
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic study of Gefitinib in a mouse model of non-small-cell lung carcinoma with brain metastasis.
Chen Y; Wang M; Zhong W; Zhao J
Lung Cancer; 2013 Nov; 82(2):313-8. PubMed ID: 24011632
[TBL] [Abstract][Full Text] [Related]
9. ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium.
Münsterberg J; Loreth D; Brylka L; Werner S; Karbanova J; Gandrass M; Schneegans S; Besler K; Hamester F; Robador JR; Bauer AT; Schneider SW; Wrage M; Lamszus K; Matschke J; Vashist Y; Uzunoglu G; Steurer S; Horst AK; Oliveira-Ferrer L; Glatzel M; Schinke T; Corbeil D; Pantel K; Maire C; Wikman H
Neuro Oncol; 2020 Jul; 22(7):955-966. PubMed ID: 32064501
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases.
Huang RSP; Harries L; Decker B; Hiemenz MC; Murugesan K; Creeden J; Tolba K; Stabile LP; Ramkissoon SH; Burns TF; Ross JS
Oncologist; 2022 Oct; 27(10):839-848. PubMed ID: 35598205
[TBL] [Abstract][Full Text] [Related]
11. Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer.
Zhang C; Mao M; Guo X; Cui P; Zhang L; Xu Y; Li L; Han X; Peltzer K; Xiong S; Baklaushev VP; Wang X; Wang G
BMC Cancer; 2019 Mar; 19(1):238. PubMed ID: 30876473
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer.
Wei C; Zhang R; Cai Q; Gao X; Tong F; Dong J; Hu Y; Wu G; Dong X
Aging (Albany NY); 2019 Sep; 11(17):6734-6761. PubMed ID: 31498117
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of PD-1/L1 inhibitors in brain metastases of non-small-cell lung cancer: pooled analysis from seven randomized controlled trials.
Li W; Jiang J; Huang L; Long F
Future Oncol; 2022 Jan; 18(3):403-412. PubMed ID: 34787500
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid as a liquid biopsy for molecular characterization of brain metastasis in patients with non-small cell lung cancer.
Tsakonas G; Tadigotla V; Chakrabortty SK; Stragliotto G; Chan D; Lewensohn R; Yu W; Skog JK; Hydbring P; Ekman S
Lung Cancer; 2023 Aug; 182():107292. PubMed ID: 37423059
[TBL] [Abstract][Full Text] [Related]
15. Identification of subgroup patients with stage IIIB/IV non-small cell lung cancer at higher risk for brain metastases.
Hsiao SH; Chung CL; Chou YT; Lee HL; Lin SE; Liu HE
Lung Cancer; 2013 Nov; 82(2):319-23. PubMed ID: 24018025
[TBL] [Abstract][Full Text] [Related]
16. The incidence and clinical impact of bone metastases in non-small cell lung cancer.
Kuchuk M; Kuchuk I; Sabri E; Hutton B; Clemons M; Wheatley-Price P
Lung Cancer; 2015 Aug; 89(2):197-202. PubMed ID: 26003503
[TBL] [Abstract][Full Text] [Related]
17. Effects of epidermal growth factor receptor-tyrosine kinase inhibitors alone on EGFR-mutant non-small cell lung cancer with brain metastasis.
Zhang Q; Zhang X; Yan H; Jiang B; Xu C; Yang J; Chen Z; Su J; Wu YL; Zhou Q
Thorac Cancer; 2016 Nov; 7(6):648-654. PubMed ID: 27755835
[TBL] [Abstract][Full Text] [Related]
18. The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis.
Chang WY; Wu YL; Su PL; Yang SC; Lin CC; Su WC
PLoS One; 2018; 13(2):e0192161. PubMed ID: 29447182
[TBL] [Abstract][Full Text] [Related]
19. Brain metastases from small cell lung cancer and non-small cell lung cancer: comparison of spatial distribution and identification of metastatic risk regions.
Shi W; Wang Y; Xia W; Liu B; Ni M; Shen J; Bai Y; Weng G; Liu W; Yuan S; Gao X
J Neurooncol; 2023 Jan; 161(1):97-105. PubMed ID: 36520380
[TBL] [Abstract][Full Text] [Related]
20. A "Seed-and-Soil" Radiomics Model Predicts Brain Metastasis Development in Lung Cancer: Implications for Risk-Stratified Prophylactic Cranial Irradiation.
Chu X; Gong J; Yang X; Ni J; Gu Y; Zhu Z
Cancers (Basel); 2023 Jan; 15(1):. PubMed ID: 36612303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
